FDA, FTC Warn Company Marketing Unapproved Cannabidiol Products With Claims to Treat Teething Pain in Infants
October 22, 2019
October 22, 2019
WASHINGTON, Oct. 22 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:
* * *
- FDA is also working quickly to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD
* * *
Today, the U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, Florida, for illegally selling . . .
* * *
- FDA is also working quickly to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD
* * *
Today, the U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, Florida, for illegally selling . . .